(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SAREPTA THERAPEUTICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

SAREPTA THERAPEUTICS

ST13

US500000085824699

Class

1

Filing

85824699

Registration

4724240

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

50

Latest update

09/10/2025

Classification

Registered

Trademark type

Word

Nice classes

1

Filing date

01/16/2013

Registration date

04/21/2015

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/16/2025

Last transaction

09/10/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

07/12/2012

First use in commerce

10/15/2014

Drawing code

4

Owner type

03

Owner location

CAMBRIDGE, MA

Examiner

SALEMI, DOMINICK

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

SAREPTA THERAPEUTICS, INC.
SAREPTA THERAPEUTICS, INC.
SAREPTA THERAPEUTICS, INC.

Representatives

Paul C. Llewellyn Arnold & Porter Kaye Scholer LLP

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

chemical compounds and additives for use in pharmaceutical research or the manufacture of pharmaceuticals

Publications

History of USPTO decisions and trademark events.

50 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

08/16/2025

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

08/16/2025

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/16/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/16/2025

E89R

TEAS SECTION 8 & 9 RECEIVED

04/02/2025

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

04/21/2024

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

04/03/2021

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

04/03/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/03/2021

E815

TEAS SECTION 8 & 15 RECEIVED

12/18/2020

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

04/21/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/02/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

04/21/2015

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/18/2015

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/18/2015

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

03/18/2015

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/17/2015

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/24/2015

SUPC

STATEMENT OF USE PROCESSING COMPLETE

02/23/2015

EX3G

SOU EXTENSION 3 GRANTED

02/23/2015

IUAF

USE AMENDMENT FILED

01/29/2015

EXT3

SOU EXTENSION 3 FILED

01/29/2015

EEXT

SOU TEAS EXTENSION RECEIVED

01/29/2015

EISU

TEAS STATEMENT OF USE RECEIVED

01/29/2015

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/06/2014

EX2G

SOU EXTENSION 2 GRANTED

08/05/2014

EXT2

SOU EXTENSION 2 FILED

07/28/2014

EEXT

SOU TEAS EXTENSION RECEIVED

07/28/2014

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/19/2013

EX1G

SOU EXTENSION 1 GRANTED

11/18/2013

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/12/2013

EXT1

SOU EXTENSION 1 FILED

10/10/2013

EEXT

SOU TEAS EXTENSION RECEIVED

10/10/2013

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/18/2013

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/16/2013

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/16/2013

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/06/2013

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/11/2013

PUBO

PUBLISHED FOR OPPOSITION

06/11/2013

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/22/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

05/08/2013

ALIE

ASSIGNED TO LIE

05/08/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/30/2013

XAEC

EXAMINER'S AMENDMENT ENTERED

04/30/2013

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/30/2013

GNEA

EXAMINERS AMENDMENT E-MAILED

04/30/2013

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/30/2013

DOCK

ASSIGNED TO EXAMINER

04/29/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/23/2013

NWAP

NEW APPLICATION ENTERED

01/19/2013

Continuous trademark protection

Get notified about every new filing that threatens SAREPTA THERAPEUTICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.